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 ORIGINAL ARTICLE 
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 Abstract 
 Background: Iron acquisition is essential for the growth of Mycobacterium tuberculosis. Hepcidin is known as an 
antimicrobial peptide and a component of the innate immune response. Hepcidin inhibits M. tuberculosis growth in vitro. 
In this study, we decided to identify   582A   G variants of the  HAMP promoter in patients with tuberculosis (TB) and 
investigate its effect on serum iron, ferritin, and hepcidin levels. Methods: The sample population consisted of 105 patients 
with TB and 104 healthy individuals. The   582A   G polymorphism was genotyped using a tetra-primers PCR set. Serum 
levels of hepcidin were determined using an ELISA kit. Statistical analysis was performed using SPSS software. 
 Results: The G allele is meaningfully associated with TB disease (95% confi dence interval    2 – 4.8,  p   0.000). Signifi cant 
differences were seen in the levels of serum iron and hepcidin but not ferritin between the   582A  G polymorphism 
genotypes. There was signifi cant reverse correlation between hepcidin and iron ( r     0.849,  p    0.006).  Conclusion: A high 
association was found between serum hepcidin levels and the  HAMP   582A   G variants in patients with TB. These 
observations indicate a hypothetical role of this polymorphism in iron metabolism. Hepcidin could perhaps be an option 
for the treatment of TB.  
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 Introduction 
 Tuberculosis (TB) is one of the most critical infec-
tious diseases in the world. In 2012, it had an 
incidence about 9.4 million cases and 1.3 million 
people died from TB. One-third of the worldwide 
population is generally thought to be latently infected 
[1], although only 10% of infected individuals 
develop TB [2]. Iron acquisition is essential for the 
growth of Mycobacterium tuberculosis (MTB) [3]. 
 Hepcidin is known as an antimicrobial peptide 
and a component of the innate immune response, 
and it inhibits MTB growth in vitro [4]. Moreover, 
this molecule affects a variety of physiological pro-
cesses and also functions as a signaling mediator in 
host defense and infl ammation [5]. The hepcidin 
antimicrobial peptide ( HAMP ) gene is mainly 
expressed in the liver in iron overload states [6]. 
Hepcidin regulates iron homeostasis by decreasing 
iron content of blood through inhibition of intestinal 
iron absorption and macrophage iron release [7 – 10]. 
Hepcidin binds ferroportin, a mammalian iron 
exporter, and causes its internalization and degrada-
tion, resulting in the inhibition of iron fl ow [11]. 
Ferroportin is expressed highly on duodenal entero-
cytes and macrophages [12]. When hepcidin levels 
increase, both dietary iron uptake and recycling iron 
resulting from decomposition of senescent red cells 
by macrophages are decreased. MTB in human 
monocyte-derived macrophages can acquire iron 
bound to ferritin, transferrin, and citrate [13]; 
therefore, high hepcidin levels lead to the reduced 
availability of iron for MTB. Anemia is a common 
complication of high hepcidin levels due to the 
reduced iron supply for erythropoiesis in bone mar-
row [14]. Iron overload and infl ammation stimulate 
hepcidin expression. Hepcidin synthesis is also 
suppressed by anemia and hypoxia [15,16]. 
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 Review of previous studies indicates that 
  582A   G variants are associated with hepcidin 
promoter activity [17 – 19] and, therefore, may play a 
role in iron overload. In this study, we decided to 
identify   582A   G variants of the  HAMP promoter 
in TB patients and investigate their effect on serum 
iron, ferritin, and hepcidin levels. 
 Material and methods 
 Sample preparation 
 The sample population of this study consisted of 105 
patients with TB and 104 healthy individuals who 
had not received regular iron chelation therapy for 
several months. They were recruited from medical 
centers of Golestan province in northern Iran. Infor-
mation on the patients ’ serum iron and ferritin levels 
was extracted from medical records. Blood samples 
were collected, and genomic DNA was extracted 
from whole blood using a QIAamp DNA Blood Mini 
kit (Qiagen, Hilden, Germany). 
 Genotyping of   582A   G variants 
 The rs10421768 single nucleotide polymorphism 
located in 582 base pairs (bp) upstream translation 
initiation codon was genotyped by using a tetra-primers 
PCR set. Primer design was performed using Gene 
Runner software (version 3.05; Hastings, USA) and 
 HAMP gene sequence information (GenBank accession 
no. NG_011563) (Table I). PCR was performed using 
Taq DNA Polymerase 2x Master Mix RED (Ampli-
qon, Copenhagen, Denmark) with 50 – 100 ng of DNA 
and 5 pmol of each primer on a thermal cycler 
(Bio-Rad, Munich, Germany). PCR conditions included 
one step initial denaturation (95 ° C for 10 min), 35 
cycles (95 ° C for 30 s, 60 ° C for 30 s, and 72 ° C for 30 s), 
and a fi nal extension at 72 ° C for 7 min. Following ampli-
fi cation, PCR products were electrophoresed in a 2% 
agarose gel (Fermentas, Sankt Leon-Rot, Germany). 
 Hepcidin ELISA assay 
 Serum samples were collected from patients by 
centrifugation of blood samples at 1500  g for 10 min. 
Serum levels of hepcidin were determined using a 
commercial ELISA kit (DRG, GmbH, Marburg, 
Germany) according to the manufacturer ’ s protocol. 
The fi nal solution color was photometrically mea-
sured at 450/630 nm wavelength with a microplate 
reader (Bio-Rad). The 5 – 95% range in normal 
healthy adults is 13.3 – 54.4 ng/ml according to the 
manufacturer. 
 Statistical analysis 
 Statistical analysis was performed using SPSS soft-
ware (version 17.0; Chicago, USA). The frequencies 
of associations between genotypes and disease were 
analyzed using chi-squared and Fisher ’ s exact tests. 
The differences seen in the values of the biochemical 
indicators among the   582A   G genotypes were 
tested by the Kruskal – Wallis test. The relationship 
between variables was estimated by Pearson correla-
tion analysis. A  p value    0.05 was considered 
signifi cant. 
 Results 
 The alleles were determined by product size band; 
317 bp for the A allele, 150 bp for G allele, and 
440 bp for control, as shown in Figure 1. 
 The genotype and allele frequencies of the TB 
patient group and control group are demonstrated 
in Table II. The wild-type genotype (AA) was 
observed in 21 (20%) of the patients, whereas 72 
(68.6%) were heterozygous (GA) and 12 (11.4%) 
were homozygous (GG). The control group included 
66 (63.5%) individuals with AA, 32 (30.8%) with 
GA, and 6 (5.7%) with GG. There were highly sig-
nifi cant differences regarding   582A   G polymor-
phism of  HAMP between TB patients and the control 
group (Table II). The results indicate that G allele is 
meaningfully associated with the TB disease (95% 
confi dence interval [95% CI]    2 – 4.8,  p    0.000). 
The  HAMP   582A   G genotypes in TB patients 
and the control group were in accordance with 
Hardy – Weinberg equilibrium. 
 Signifi cant differences were seen in the serum iron 
and hepcidin levels in   582A   G polymorphism 
 Table I. Primers used for   582A   G polymorphism determination and sequence analysis. 
Description Primer Sequence (5 ′ → 3 ′ )
  582 A   G Forward outer CTTAAGCGATCTGCCTCAG
Reverse outer AGGAGTGTCTGGCATGTTG
Forward inner (G) GGTCTGACACTGGGAAAACAGCG
Reverse inner (A) GTGTGCCCGATCCGCCCGT
Sequence analysis Forward TGATATCCCAAAGAAGAGTAGC
Reverse CAACTTTCCTGGCAACCTC
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genotypes (Table III). These results indicate that iron 
levels in GA and GG genotypes have higher values 
( p    0.003). Unlike iron, hepcidin concentration 
decreased in GA and GG genotypes ( p    0.030). 
Based on the results in Table IV, there was signifi -
cant reverse correlation between hepcidin and 
iron ( r     0.849,  p    0.006) and no signifi cant cor-
relation between hepcidin and ferritin ( r    0.151, 
 p    0.341). 
 Discussion 
 MTB as a cause of TB disease requires iron for 
growth and replication [3]. Hepcidin is an antimicro-
bial peptide that regulates iron homeostasis [20,21], 
and better understanding of its role in TB disease 
may be interesting. With regard to the points men-
tioned, there are not many studies on the relationship 
of hepcidin to TB disease development [4,22]. In 
this work, we genotyped   582A   G polymorphism 
located in the  HAMP gene promoter in TB patients 
and the control group and its relationship with serum 
iron, ferritin, and hepcidin. In the present work, the 
correlation of   582A   G variants to TB disease was 
highly signifi cant (Table II) and no studies have 
been reported previously. Our results on the associa-
tion of   582A   G polymorphism to serum iron 
and hepcidin are in agreement with the study by 
Andreani et  al. [17] and in contrast with work by 
Bruno et  al. that did not fi nd any association [19]. 
We report a reverse correlation between hepcidin 
and iron in the way that high hepcidin decreases the 
iron level (Table IV), as has been reported in previ-
ous studies [7,23,24]. The   582A   G variants dem-
onstrated an impact on the level of hepcidin 
expression and its subsequent increase in serum iron 
in TB patients. These observations suggest that 
  582A   G polymorphism may be associated with 
changes in the  HAMP promoter function. This 
 HAMP promoter substitution, therefore, might rep-
resent a risk factor for TB patients by promoting iron 
overload in them. 
 Figure 1. Electrophoresis pattern of PCR for detection of 
  582A   G polymorphism. 
 Table II. The genotypes and alleles distribution of   582A   G polymorphism in case and control 
groups. 
Characteristic
TB group, 
 n (%)
Control group 
 n (%)
Odds ratio 
(95% CI)  p value
Genotypes
AA 21 (20) 66 (63.5) 1
GA 72 (68.6) 32 (30.8) 7 (3.7 – 13.5)    0.0001
GG 12 (11.4) 6 (5.7) 6.1 (2.1 – 19.8) 0.0009
A/G   G/G 84 (80) 38 (36.5) 6.9 (3.7 – 12.9)    0.0001
Alleles
A 114 (54.3) 164 (78.9) 1
G 96 (45.7) 44 (21.1) 3.1 (2 – 4.8)    0.0001
 CI, confi dence interval; TB, tuberculosis. 
 Table III. Levels of serum iron, ferritin, and hepcidin according to  HAMP   582A   G genotype in patients with tuberculosis (TB). 
  582A   G genotypes
Characteristic A/A A/G   G/G  p value Normal range
 n (%) 21 (20) 84 (80)
Serum iron, mean   SD ( μ g/dl) 31.6    17.7 53.5    16.2 0.003 45 – 160 males; 40 – 150 females
Serum ferritin, mean   SD (ng/ml) 31.9    28.7 39.6    35.5 0.045 10 – 295 males; 25 – 325 females
Serum hepcidin (ng/ml), geometric mean (95% range) 57.5 (21.9 – 88.7) 35.2 (17.4 – 53.1) 0.030 13.3 – 54.4 adults
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 Conclusion 
 Due to the impact of hepcidin on iron level, differ-
ences in the level of hepcidin expression may par-
tially relate to the phenotypic variants in iron 
hemostasis among TB patients. In the present study, 
a high association was found between serum hepci-
din level and the  HAMP   582A   G variants in TB 
patients. These observations indicate a hypothetical 
role of this polymorphism in iron metabolism. This 
assay can be useful as part of the diagnostic and 
prognostic evaluation in TB disease. Hepcidin could 
perhaps be an option for the treatment of TB. 
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